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Summary 
We studied 42 women with severe Premenstrual Tension Syndrome (PMTS) and 
compared their clinical features and adrenocortical function with those seen in major 
depressive disorders. Self-report scales demonstrated that PMTS was very distress- 
ing, but the disturbance did not meet the RDC for Major Depressive Disorder - 
endogenous subtype. Twenty-four hour urinary free cortisol estimation did not 
indicate cortisol hypersecretion and abnormal Dexamethasone Suppression Test 
results occurred much less frequently than is usual in endogenous depression. 
Adrenocortical function did not differ significantly between follicular and pre- 
menstrual phases. PMTS doe s not appear to be a psychoendocrine model for 
endogenous depression. 
Key words: Dexamethasone Suppression Test ~ Endogenous depression - Premenstr- 
uul Tensiorl Syndrome - Ps.vchoendocrine stud) 
Introduction 
Women suffering from severe Premenstrual Tension Syndrome (PMTS) experi- 
ence a number of distressing emotional and behavioral changes during the pre- 
menstruum. This disturbance, by definition, shows a temporal relationship to the 
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cyclic fluctuations by the pituitary-gonadal system and it was anticipated that 
endocrine studies might increase our understanding of PMTS. Unfortunately, the 
measurement of various hormone plasma levels associated with this syndrome has 
not yielded particularly reliable or informative results (see Abplanalp et al. 1980 for 
review). An alternative strategy would be a search for those endocrine abnormalities 
that have been noted to be associated with specific forms of psychopathology. The 
presence of such phenomena might suggest some similarity between the pathophysi- 
ology of PMTS and other psychiatric disorders. 
The hypothalamic-pituitary-adrenocortical (HPA) axis is the most intensively 
studied endocrine system in situations of altered psychological state and some 
specific associations have been described. Adrenocortical activity is noted to increase 
in response to various stressful stimuli and is persistently elevated in many patients 
during an episode of endogenous depression (ED) (see Carroll 1977 for review). The 
clinical similarities between PMTS and some depressive disorders would be of 
greater heuristic significance if these women also demonstrated disinhibition of the 
HPA axis, similar to that seen in patients with ED. Although estrogen or pro- 
gesterone treatment, or pregnancy, alter adrenocortical function (Bulbrook et al. 
1973; Lindholm and Schultz-Moller 1973; Hellman et al. 1976). evaluation of this 
system in PMTS is facilitated by the apparent absence of cyclic fluctuations in 
baseline cortisol secretion in medication-free women with normal menstrual cycles 
(Aubert et al. 1971; Saxena et al. 1974: Carr et al. 1979). 
Urinary measures of cortisol excretion during a 24-h period provide an integrated 
measure of adrenocortical functioning over time. This is preferred to the measure- 
ment of plasma cortisol levels, since the pulsatile release pattern of cortisol limits the 
amount of information provided by the latter method unless frequent blood samples 
are obtained. Urinary free cortisol (UFC) is reported to reflect the effective level of 
free plasma cortisol better than any other urinary parameter (Greaves and West 
1960; Kosner et al. 1963, 1964; Burke and Beardwell 1973; Beisel et al. 1964). 
This study compared the clinical features of severe PMTS with the syndrome of 
ED. Indices of adrenocortical function that are abnormal in many patients with ED, 
such as 24-h UFC (Carroll et al. 1976a) and the 1 mg Dexamethasone Suppression 
Test (DST) (Carroll et al. 1981) were also assessed in these women. In addition, to 
evaluate the possible contribution of a non-specific stress response to HPA axis 
activation, we examined the relationship between cortisol excretion and reported 
levels of psychological distress. 
Material and Method 
Forty-two women between the ages of 22 and 42 years were selected from more 
than 250 volunteers for a study of severe PMTS. Each woman gave informed 
consent, reported at least moderate or severe emotional and physical symptoms 
during the premenstrual phase and noted rapid remission of the disturbance soon 
after the onset of menses. Subjects were free of other significant physical or 
psychiatric disorders, had regular menstrual cycles for at least the preceding 6 
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months and were not taking oral contraceptives or other medications known to 
affect endocrine functioning. The selection process extended over 224 cycles and 
included interviews during both follicular unri premenstrual phases (Haskett et al. 
1980). 
Clinical interviews, self-report scales and endocrine measurements were per- 
formed for each subject at each of two visits during the menstrual cycle. A follicular 
phase visit occurred on Day 9, where Day 1 was the first day of menses, and a 
late-luteal phase visit was on Day 26 which always occurred 3-7 days premenstru- 
ally. During each clinical interview. subjects were asked about the presence of the 
features of PMTS. In addition, information was obtained on the symptoms and signs 
necessary for psychiatric syndromal categorization according to the Research Di- 
agnostic Criteria (RDC) (Spitzer et al. 1977). 
Before each interview, subjects were instructed to record their current state on the 
following self-report scales: Visual Analogue Scale (VAS) (Aitken 1969; Maxwell 
1978) Menstrual Distress Questionnaire-Today form (MDQ-T) (Moos 1968) Multi- 
ple Affect Adjective Checklist (MAACL) (Zuckerman and Lubin 1965), and the 
State form of the State/Trait Anxiety Inventory (STAI-STATE) (Spielberger et al. 
1970). The Visual Analogue Scale is a 100 mm line labelled ‘no symptoms’ at one 
end and ‘worst ever’ at the other. The subject marked this line at an appropriate 
point to make a subjective estimate of global discomfort. The MDQ-T is a scale on 
which women can rate their current experience of 47 symptoms at any point in the 
menstrual cycle. The STAI-STATE and MAACL have been used and validated 
extensively. 
Thirty-eight women completed a 1 mg DST at the time of the follicular and 
premenstrual phase visits. UFC was measured in urine collected during the 24-h 
periods immediately before and after the 11:30 p.m. dose of 1.0 mg dexamethasone. 
Total plasma cortisol was estimated from a blood sample drawn at 4 p.m. on the 
second day according to the standard DST procedure for outpatients (Carroll et al. 
1981). Cortisol was measured in plasma and urine by the competitive-protein-bind- 
ing methods of Murphy (1967, 1968) with modifications described by Carroll et al. 
(1976b). 
Results 
All 42 subjects complained of a prominent dysphoric mood when interviewed 
during the premenstrual visit. The clinical disturbance reported by each woman at 
that time, only met the RDC for Major Depressive Disorder (MDD) if the duration 
of symptoms criterion in this diagnostic category was reduced from 2 weeks to 2 
days. None, however, met criteria for the endogenous subtype. At the follicular visit, 
psychopathology was either absent or minimal and no subject met RDC for any 
category of psychiatric illness. 
The self-report scales completed by this group of women demonstrated that 
PMTS was associated with a marked increase in symptoms (Tables 1 and 2). During 
the fol/icu/ur phase, the mean score on the STAI-STATE was comparable to the 
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scores obtained from an asymptomatic group of female volunteers on Day 14 of 
their menstrual cycle (Gnlub 1976). By comparison, the ptwwwstrucrl phase score 
from the women in this study was much higher than that reported in the group 
studied by Golub (1976). The severity of the disturbance experienced by these 
women is evident from a comparison of the mean premenstrual STAI-STATE score 
in this study (55) with the scores obtained from psychiatric patients with an anxiety 
reaction (49) or depressive reaction (54) (Spielberger et al. 1970). 
Twenty-four-hour [!FC dues obtained during the DST are summarized in Table 
3. Mean values for the group showed no evidence of cortisol hypersecretion before 
dexamethasone ( < 100 pg,/24 h) and indicated normal suppression of cortisol 
secretion after dexamethasone ( < 25 pg/24 h). The mean baseline UFC excretion 
values of 46.7 and 47.9 pg/24 h were no different than those found by Murphy 
TABLE 2 
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(1968) in normal subjects (48 pg/24 h). Despite the definitive premenstrual increase 
in symptoms, UFC values obtained in the premenstrual and follicular phases were 
not significantly different. 
Predexamethasone 24-h UFC values were compared with total scores on the VAS, 
MDQ-T, STAI-STATE, and each of three subsets of items on the MAACL repre- 
senting the dimensions of depression (MAACL-D), anxiety (MAACL-A) and hostil- 
ity (MAACL-H). Results from the follicular and premenstrual phase visits were 
TABLE 3 
URINARY FREE CORTISQL EXCRETION (pg,‘24 h) 
Result, are means with SD. range in parentheses. 
Follicular Premenstrual P 
phase phase 
Predexamethasone 
(Normal < 100) 
Postdexamethasone 
(Normal < 25) 
46.7 (30.9-70.8) 47.9 (29.5-77.6) NS 
4.7 (1.9-10.3) 5.8 (2.3-12.6) NS 
TABLE 4 
CORRELATIONS BETWEEN PRE-DEXAMETHASONE (BASELINE) 24-H UFC AND TOT.AL 
SCORES ON SELF-REPORT SCALES 
Folhcular phase 
UFC MDQ-T STAI-STATE VAS MAACL-D M.AACL-A MAACL-H 
UFC -0.1216 0.0917 -0.1294 -0.0193 0.0791 - 0.0157 
MDQ-T 0.3505 h 0.1897 0.0911 0.1951 0.2185 a 
STAI-STATE 0.2921 ” 0.2293 L’ 0.4200 h 0.4154 h 
VAS 0.2748 ’ 0.2681 a 0.3177 “ 
MAACL-D 0.6971 I’ 0.6567 ’ 
MAACL-A 0.6448 ’ 
d P i 0.05. 
h P i 0.005 
TABLE 5 
CORRELATIONS BETWEEN PRE-DEXAMETHASONE (BASELINE) 24-H UFC AND TOTAL 
SCORES ON SELF-REPORT SCALES 
Premenstrual phase 
UFC MDQ-T STAI-STATE VAS MAACL-D MAACL-A MAACL-H 
UFC 0.000 0.0943 ~ 0.0305 - 0.0117 0.0418 - 0.0176 
MDQ-T 0.3034 ‘I 0.3755 h 0.2349 J 0.2620 L’ 0.1470 
STAI-STATE 0.3822 h 0.4103 h 0.540x h 0.3354 h 
VAS 0.4716 h 0.5040 h 0.3993 h 
MAACL-D 0.4555 h 0.3497 h 
MAACL-A 0.6203 h 
a P < 0.05. 
h P < 0.005. 
considered separately. Five subjects were not included in this analysis because of 
incomplete data. Kendell’s tau, correlation coefficient was used to characterize the 
relationship between UFC measurements and concurrent ratings of self-reported 
distress. Significance of tau, was tested using the normal distribution and z scores. A 
rank-order correlation coefficient was used because there were large numbers of tied 
scores on the rating scales during the follicular phase. A summary of the results is 
presented in Tables 4 and 5. Tau, calculated for the relationship between UFC and 
the total scores on each of the self-report scales did not reach significance during 
either phase of the menstrual cycle. Significant associations were found between the 
scores obtained on many of the rating scales during the same cycle phase. 
Four women showed an abnormal DST result in the follicular phase and three 
women in the premenstrual phase. An abnormal result is indicated by a 4 p.m. 
postdexamethasone plasma cortisol value greater than 5 pg/dl. No woman had an 
abnormal result on both occasions. 
Discussion 
Our subjects were women with unusually severe emotional and behavioral dis- 
turbance during the premenstruum. This was demonstrated by the marked phase- 
related change in the mean total score on each of the self-report scales (Table 1). 
Details of these findings have been reported separately (Haskett et al. 1980). The 
presence of definite score changes on all scales reflects the broad range of symptoms 
that may be seen in PMTS. Despite the severity of symptoms, the endocrine results 
were remarkably normal. 
The frequent presence of depressed mood in PMTS has raised questions about the 
relationship between this disturbance and the depressive disorders. Demonstration 
of such a link would be of therapeutic and heuristic importance. In this study we 
used a criterion-based diagnosis (RDC) and a neuroendocrine marker (DST) to 
compare PMTS with ED. The study subjects met the criteria for the relatively 
heterogeneous category of MDD during the premenstruum but only after the 
arbitrary abbreviation of the duration criterion. Their clinical features did not, 
however, resemble the typical syndrome of ED. 
In addition, the typical HPA axis dysfunction reported in many patients with ED 
was only occasionally seen in these subjects. There was no association between the 
premenstrual disorder and hypercortisolemia or resistance of cortisol secretion to 
suppression by dexamethasone. The rate of abnormal DST result was much lower 
than that reported in patients with ED and did not significantly change between 
follicular and premenstrual phases of the menstrual cycle (Fig. 2). Thus, in these 
women with no other psychiatric disorder, PMTS did not appear to be a model for 
ED. 
The HPA axis is also a sensitive marker of physiological responsivity to a variety 
of noxious events (see Mason 1968 for review). Some reports have suggested that the 
symptoms of PMTS occur in response to psychological stressors and many different 
intrapsychic and environmental stimuli have been proposed (Benedek 1952: Fortin 
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Fig. 1. Frequency of abnormal result for Dexamethasone Suppression Teat admmratered to 3X women 
with PMTS during the follicular and premenstrual phases of their cycles. This is compared with results 
obtained from two groups of psychiatric outpatients. 
et al. 1958; Paulson 1961; Paige 1971; Rees 1976; Taylor 1979). We were unable to 
show a significant relationship between 24-h baseline UFC excretion and the 
severity of symptoms, as measured by total scores on any of the self-report scales. 
This was noted during the follicular phase, when subjects were relatively 
asymptomatic, as well as during the premenstrual phase when all subjects were 
severely affected by PMTS. This is particularly intriguing, since Marinari et al. 
(1976) reported that asymptomatic women had a greater response of plasma cortisol 
to a stressful stimulus given during the premenstrual phase compared with ‘mid- 
cycle’. Even a study which could not show a difference in cortisol responsivity 
between midcycle and menstrual phases. did note that the adrenocortical response 
was closely related to the anxiety level experienced after the stressful stimulus 
(Abplanalp et al., 1977). In our subjects, neither the currently unidentified cause of 
PMTS. nor the experience of the disturbance resulted in a significant mean dif- 
ference in cortisol excretion between follicular and premenstrual phases of the cycle. 
HPA axis functioning does not appear to be a useful neuroendocrine marker of the 
distress that is reported by women suffering from severe PMTS. 
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